MTC prognosis accurately predicted by 18F-DOPA PET/CT

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Abnormal findings on 18F-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography (PET)/CT are associated with reduced PFS and disease-specific survival (DSS) in patients with recurrent medullary thyroid carcinoma (MTC).

Why this matters

  • 18F-DOPA PET/CT may represe...